INSPIRE
Innovative Support For Patients with SARS COV-2 Infections Registry
Project Summary:
The INSPIRE study is a multi-institutional, longitudinal cohort study that focuses on the association of age and other vulnerabilities with clinical outcomes and patient-reported outcomes in people infected with the coronavirus illness (COVID-19) as well as a concurrent control group who were under investigation but tested negative. This study is designed to expand the knowledge base related to this infection, and produce results that: are expected to be applicable to a larger population beyond the site of data collection or the specific subjects studied.
Population:
Adults, age 18 or older, who have experienced symptoms of COVID-19 and have been tested within the last 4 weeks. Enrollment will take place from two populations: seeking testing but having a negative result and testing positive, across outpatient (including ED) and inpatient (including ICU). A total of 4800 subjects will be enrolled with 3600 active and 1200 controls.
Outcomes:
Patient-reported outcomes include self-reported health function and status, as well as clinical outcomes including health system encounters and new diagnoses.
Enrollment:
3,830 total enrolled as of 2/17/22
Study Team:
Ryan Huebinger, MD (Principal Investigator) | Mandy Hill, DrPH, MPH (Co-Principal Investigator) | Leslie Johnson (Research Coordinator) | Arun Kane (Research Coordinator) | Sarah Sapp, MPH (Research Assistant) | researchers assistants from UTHealth School of Public Health
Dissemination:
Preprint manuscripts:
Funding and Collaborators:
Study Teams:
The INSPIRE study is an eight-center national project, in collaboration with Hugo Health, with Rush University as the lead research site.
参与机构包括:
